Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Toll-like receptor signaling pathway variants and prostate cancer mortality.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Jun 2009

Stark Jennifer R, Wiklund Fredrik, Grönberg Henrik, Schumacher Fredrick, Sinnott Jennifer A, Stampfer Meir J, Mucci Lorelei A, Kraft Peter

Abstract excerpt

An understanding of factors associated with prostate cancer (PCa) mortality is increasingly important given the biological heterogeneity of disease. Previous studies have shown that genetic variation in the Toll-like receptor (TLR) signaling pathway is associated with PCa incidence, but any role in progression and mortality is unclear. Among 1,252 PCa cases from the Cancer Prostate in Sweden study, we conducted...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Neoplasm Staging

Share to Polymorphism, Single Nucleotide

Share to Prostatic Neoplasms

Share to Signal Transduction

Share to Toll-Like Receptors

Source

Open in PubMed Open full text

Identifiers

PMID: 19505919
DOI: 10.1158/1055-9965.EPI-08-0981
PMCID: PMC2833418

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Toll-like receptor signaling pathway variants and prostate cancer mortality.PMID 19505919Read ↗

Genetic variation in the toll-like receptor 4 and prostate cancer incidence and mortality.Semantic proximity Read ↗

Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk.Semantic proximity Read ↗

Genetic variation in the toll-like receptor gene cluster (TLR10-TLR1-TLR6) and prostate cancer risk.Semantic proximity Read ↗

Sequence variants in the TLR4 and TLR6-1-10 genes and prostate cancer risk. Results based on pooled analysis from three independent studies.Semantic proximity Read ↗

Prostate cancer (PCa) risk variants and risk of fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.Semantic proximity Read ↗

Polymorphisms of an innate immune gene, toll-like receptor 4, and aggressive prostate cancer risk: a systematic review and meta-analysis.Semantic proximity Read ↗

Sequence variants of Toll-like receptor 4 and susceptibility to prostate cancer.Semantic proximity Read ↗

Association between Toll-like receptor gene cluster (TLR6, TLR1, and TLR10) and prostate cancer.Semantic proximity Read ↗

Sequence variants of toll-like receptor 4 are associated with prostate cancer risk: results from the CAncer Prostate in Sweden Study.Semantic proximity Read ↗

Association of Toll-like receptor (TLR) 2, 3 and 9 genes polymorphism with prostate cancer risk in North Indian population.Semantic proximity Read ↗

Toll-like receptor 4 genetic variation and advanced prostate cancer risk.Semantic proximity Read ↗

Vitamin D-related genetic variation, plasma vitamin D, and risk of lethal prostate cancer: a prospective nested case-control study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.